Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
1001 results
D3.380 - The Most Serious Threat in Perioperative Hypersensitivity Reactions (PHRs): Neuromuscular Blocking Agent (NMBA) Hypersensitivity and Cisatracurium as a Safe Haven in the Setting of Cross-Reactivity
D3.381 - The paradox of treatment: H1-antihistamines-induced urticaria in a patient with chronic spontaneous urticaria
D3.382 - Safety and outcomes of penicillin desensitization during pregnancy: experience from a tertiary referral center
D3.383 - Delayed T-cell–mediated hypersensitivity to dimethyl fumarate: clinical presentation and diagnostic considerations
D3.384 - Assessment of the role of Rapid Drug Desensitization to treat cancer patient with infusion-related allergic reactions. Italian experience
D3.385 - A Synthetic Serum Comprising Human IgE Monoclonal Antibodies to Peanut Allergens
D3.386 - Prevalence and immune mechanisms of rheumatoid arthritis in Kyrgyz highland residents
D3.398 - Primary Care Physicians’ Perspectives on Primary Immunodeficiency Diseases
D3.401 - A mechanism for loss of biodiversity in the gut: Toxic effects and metabolic alterations of food additives on human fecal microbiome
D3.404 - From CVID to CTLA-4 Haploinsufficiency: The Impact of Genetic Diagnosis on Targeted Therapy
D3.407 - Angioedema: cause or consequence?
D3.408 - When Angioedema Is Not Angioedema: EBV-Associated Lymphocytic Inflammation Mimicking Hereditary Angioedema
D3.415 - Galectin-10 Expression in Plasma-Derived Extracellular Vesicles of Patients with Eosinophilic Esophagitis: a Pilot Study
D3.430 - The effect of biological treatment of atopic dermatitis in children
D3.431 - Dupilumab therapy of patients with chronic rhinosinusitis with nasal polyps: long-term observational study
D3.432 - Severe chronic rhinosinusitis - diagnostic and therapeutic challenges, personalized approach and place of biological treatment: a clinical case
D3.433 - An effect on lipid profile of biologic therapy independent from weight variation
D3.434 - Effectiveness of Biologic Therapies in Adults With Chronic Rhinosinusitis With Nasal Polyps: Real-World Data
D3.435 - “Looking Twice in Atopic Dermatitis Therapy: Pruritus Is Not Always the Same, and Eczema Is Not Always Atopic Dermatitis”
D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial
Pagination
First page
First
Previous page
Previous
…
Page
43
Page
44
Page
45
Page
46
Page
47
Page
48
Current page
49
Page
50
Page
51
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download